When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - FDA's OKs new use of Acceleron and Bristol-Myers Squibb's luspatercept
Bristol-Myers Squibb Company
Acceleron Pharma (NASDAQ:XLRN) and collaboration partner Bristol-Myers Squibb (NYSE:BMY) announce the FDA nod for Reblozyl (luspatercept-aamt) for the treatment of anemia in certain adult patients with very low-to-intermediate-risk myelodysplastic syndromes who have failed treatment with an erythropoiesis stimulating agent and need at least two red blood cell units over eight weeks.
More news on: Acceleron Pharma Inc., Bristol-Myers Squibb Company, Celgene Corporation, Healthcare stocks news,